Latent Autoimmune Diabetes of Adults

If defined as a type 2 diabetic phenotype combined with islet antibodies, the prevalence of LADA is around 10% among incident situation subjects of diabetes aged 40–75 years (16). A related prevalence is found among non-insulin-requiring patients older than 35 years at diagnosis with phenotypic type 2 diabetes (17). All-cause mortality was improved by 50% for LADA patients matched with individuals without diabetes, corresponding to the outcomes seen for the whole group of adult-onset autoimmune diabetes. In addition, we show that the extra mortality risk pertains to men and women and, in particular, to death from IHD. The reason of LADA is the growth of autoantibodies against pancreatic cells, insulin, or enzymes involved in pancreatic roles. Antibodies affecting the pancreas and its function might influence the way the body answer back to blood sugar.

    Related Conference of Latent Autoimmune Diabetes of Adults

    January 27-28, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Dubai, UAE
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    February 24-25, 2025

    20th International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 10-11, 2025

    18th European Diabetes and Endocrinology Congress

    Rome, Italy
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    March 17-18, 2025

    19th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    March 24-25, 2025

    6th Global summit on Diabetes and Endocrinology

    London, UK
    April 07-08, 2025

    36th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    April 10-11, 2025

    31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    27th World Congress on Diabetes and Endocrine Disorders

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    April 16-17, 2025

    9th International Conference on Diabetes and Cholesterol Metabolism

    Tokyo, Japan
    May 05-06, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    May 12-13, 2025

    2nd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    August 11-12, 2025

    5th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 06-07, 2025

    34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Berlin, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Latent Autoimmune Diabetes of Adults Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in